Soligental
Recall
|
Veterinary Medicines
|
28/06/2013
The marketing authorization holder informed its supplied customers in a letter dated 17.06.2013 that a decrease in gentamicin content was observed in a batch of Soligental after 14 months of use (85.1%; specification: 95-105%) and that all batches of the product are therefore being recalled as a precautionary measure until the cause of the problem has been clarified and rectified at the level of the wholesalers and institutional pharmacies supplied.
| Name of the medicinal product | Soligental 3000 I.E./ml Augentropfen für Hunde und Katzen |
|---|---|
| Marketing authorisation number(s) | 8-00429 |
| Marketing authorisation holder | Virbac Laboratoires, Frankreich Durchführung des Rückrufes in Österreich: Virbac Österreich GmbH Hildebrandgasse 27 A-1180 Wien |
| Batch number(s) | Alle Chargen |
| Classification of the recall | 3 |
| BASG reference number | INS-640.001-0790 |
Further inquiry note
Page last modified:
12/07/2022